Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.56 |
| ▸ | CA2 | P00918 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.46 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.40 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.39 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ITK | Q08881 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30462444 | 0.86 | CA1 (0.54) | CA1CA2ALDH1A1KDM4EENPP3 | |
| SCHEMBL32211 | 0.86 | ALDH1A1 (0.58) | CA1CA2ALDH1A1KDM4ECYP1B1 | |
| SCHEMBL29391266 | 0.86 | ALDH1A1 (0.58) | CA1CA2ALDH1A1KDM4ECYP1B1 | |
| SCHEMBL5211903 | 0.82 | ALDH1A1 (0.50) | CA1CA2ALDH1A1KDM4ECYP1B1 | |
| SCHEMBL642740 | 0.80 | CA1 (0.48) | CA1CA2ALDH1A1KDM4EMAPT | |
| SCHEMBL1343465 | 0.80 | CA1 (0.69) | CA1CA2ALDH1A1KDM4ECYP1B1 | |
| SCHEMBL5746374 | 0.80 | MDM4 (0.51) | CA1CA2ALDH1A1KDM4ECYP1B1 | |
| SCHEMBL5747405 | 0.80 | CA1 (0.54) | CA1CA2ALDH1A1KDM4EENPP3 | |
| SCHEMBL12679885 | 0.80 | ALDH1A1 (0.50) | CA1CA2ALDH1A1KDM4ECYP1B1 | |
| SCHEMBL1344052 | 0.79 | CA1 (0.67) | CA1CA2ALDH1A1KDM4EENPP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050258743-A1 | Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2005-11-24 | — | — | US | disclosed |
| US-6906217-B2 | Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof | SONY CORPORATION (JP) | 2005-06-14 | — | — | US | disclosed |
| US-6790975-B2 | ORGANIC ELECTROLUMINESCENCE; CONDENSATION FROM A CORRESPONDING AMINOBENZALDEHYDE AND A PHOSPHONIC ESTER OR PHOSPHONIUM SALT; YELLOW TO RED LIGHT | SONY CORPORATION (JP) | 2004-09-14 | — | — | US | disclosed |
| US-20030208089-A1 | Aminostyrylanthrancene compound, synthetic intermediate thereof, and process for production thereof | JOLED INC. (JP) | 2003-11-06 | — | — | US | disclosed |
| US-20030149290-A1 | AMINOSTYRYLANTHRACENE COMPOUND, SYNTHETIC INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF | JOLED INC. (JP) | 2003-08-07 | — | — | US | disclosed |
| EP-1191015-A1 | AMINOSTYRYLANTHRACENE COMPOUNDS, INTERMEDIATES FOR THE PREPARATION THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH | Sony Corporation (JP) | 2002-03-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050258743-A1 | Aminostyrylanthracene compound, synthetic intermediate thereof, and process for production thereof | AASDHPPT, AADAT, ALDH7A1 | CA1 1102/4885CA2 907/4885ALDH1A1 1220/4885 |
| US-20030149290-A1 | AMINOSTYRYLANTHRACENE COMPOUND, SYNTHETIC INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF | AASDHPPT, AADAT, ALDH7A1 | CA1 1076/4885CA2 1158/4885ALDH1A1 847/4885 |
| US-20030208089-A1 | Aminostyrylanthrancene compound, synthetic intermediate thereof, and process for production thereof | AASDHPPT, ALDH7A1, AGPAT5 | CA1 1251/4885CA2 1169/4885ALDH1A1 1057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.